How daraxonrasib impacted one pancreatic cancer patient| STAT
The approval of daraxonrasib, a new life-extending drug for pancreatic cancer, is the biggest advance in decades against…
Atrogi’s muscle pill shows early promise in 13 people
Small open-label study of ATR-258 saw fat loss, lean mass gains and better leg power, but no placebo…
Eli Lilly, NIH grants, Novartis, Regeneron: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
GLP-1s in children, Syntis Bio, Vera: Readout Newsletter
National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways…
AI hunts new uses for Phase 3 metabolic drug
THPharm already has a drug in late-stage trials. Now it’s using AI to work backwards and find out…
Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
He cracked malaria’s genome in Mali. Now he’s advising the UN
Vitals Hometown: Koro, Mali Current position: Professor of parasitology and mycology and head of the Parasites and…
Compounded GLP-1s: Why doctors worry and the FDA is cracking down
So, are these copycat versions of the weight loss drugs safe? Poison control centers across the U.S. have…
How AI is supercharging drug development
Illustration: Aïda Amer/Axios. Stock: Getty Images Artificial intelligence is dramatically speeding up drug development — and a proprietary…